Inhibition of the p38 MAPK pathway as a strategy to overcome tumour immune suppression in CD1c+ dendritic cells
Introduction: Harnessing the potential of the immune system to destroy and eliminate cancer cells has been a long-term dream for many researchers in the field of cancer immunotherapy. The licencing of immune checkpoint inhibitors (ICI) and targeted therapies for malignancies such as malignant melano...
| Main Author: | |
|---|---|
| Format: | Thesis (University of Nottingham only) |
| Language: | English |
| Published: |
2024
|
| Subjects: | |
| Online Access: | https://eprints.nottingham.ac.uk/77971/ |